Neothetics

45 articles about Neothetics

• 

  FDA Grants Evofem Biosciences’ Amphora Fast Track Designation

  2/21/2018

  The U.S. Food and Drug Administration (FDA) granted San Diego-based Evofem Biosciences Fast Track designation for Amphora vaginal gel to prevent urogenital chlamydia infection in women.

• Evofem Announces Closing of Merger With Neothetics

  1/18/2018

  The merged company will operate as Evofem Biosciences and will focus on the continued development and commercialization of women's healthcare products.

• Neothetics Provides Business Update and Reports Third Quarter 2017 Financial Results

  11/8/2017

  Net loss for the third quarter of 2017 was $1.8 million, or $0.13 basic and diluted net loss per share, compared to a net loss of $2.4 million.

• Neothetics and Evofem Biosciences Announce Merger Agreement to Create Women’s Health Company

  10/17/2017

  The merger will position the combined company with an opportunity to become a leading women's health company that develops and commercializes novel products.

• Neothetics Provides Business Update And Reports Second Quarter 2017 Financial Results

  8/11/2017

• Neothetics to Slash an Unknown Number of Jobs, Review Strategic Alternatives

  7/11/2017

• SoCal's Neothetics Craters As Fat-Reduction Drug Flunks Phase II Study

  6/26/2017

• Neothetics Provides Business Update And Reports First Quarter 2017 Financial Results

  5/11/2017

• Neothetics To Provide A Business Update And Release First Quarter 2017 Financial Results Thursday, May 11th, 2017

  5/4/2017

• Neothetics Announces Issuance By USPTO Of Eighth Patent Directed To LIPO-202 Lead Clinical Asset

  4/5/2017

• Neothetics Provides Business Update And Reports Fourth Quarter 2016 Financial Results

  3/23/2017

• Neothetics Announces Last Subject Enrolled In Phase II Proof Of Concept Trial For LIPO-202 For The Reduction Of Submental Subcutaneous Fat

  3/20/2017

• Neothetics To Provide A Business Update And Release Fourth Quarter 2016 Financial Results Thursday, March 23, 2017

  3/16/2017

• Neothetics Initiates Phase 2 Proof Of Concept Trial For LIPO-202 For The Reduction Of Submental Subcutaneous Fat

  12/27/2016

• Neothetics Provides Business Update And Reports Third Quarter 2016 Financial Results

  11/10/2016

• Neothetics To Provide A Business Update And Release Third Quarter 2016 Financial Results Thursday, November 10, 2016

  11/3/2016

• Neothetics Provides Business Update And Reports Second Quarter 2016 Financial Results

  8/11/2016

• Neothetics To Provide A Business Update And Release Second Quarter 2016 Financial Results Thursday, August 11, 2016

  8/4/2016

• Neothetics Reports First Quarter 2016 Financial Results

  5/12/2016

• Neothetics To Release First Quarter 2016 Financial Results

  5/5/2016